COVID19 news

Peter Cov-Boost trial at CRF
Cambridge begins world-first COVID-19 vaccine booster study

Researchers in Cambridge have welcomed their first participants in a new UK study to understand the effects of a ‘booster’ dose of a COVID-19 vaccine.Read more

Graphic representing single-cell analysis of COVID patients immune response
Differing immune responses discovered in asymptomatic cases and those with severe COVID-19

A UK-wide study part-funded by the NIHR has identified differences in people’s immune responses to COVID-19, depending on whether they have no symptoms or more serious reactions to the virus.Read more

alt=""
Genomics study identifies routes of transmission of coronavirus in care homes

Genomic surveillance – using information about genetic differences between virus samples – can help identify how SARS-CoV-2 spreads in care home settings.Read more

Coronavirus image
Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission

New data suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of asymptomatic SARS-CoV-2 infections.Read more

Nasal spray
Can a tapeworm drug boost protection from Covid-19 for high-risk kidney patients?

A new trial led by Cambridge launches to see if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high-risk kidney patients.Read more

Pfizer BioNTech vaccine likely to be effective against B1.1.7 strain of SARS-CoV-2

The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy is modestly affected. However, when the E484K mutation – first seen in the South African variant – is added, it substantially increases the amount of antibody required to prevent infection.Read more

Man suffering effects of fatigue
New research suggests COVID-19 severity can be predicted in hospitalised patients

Research conducted at Addenbrooke’s hospital and supported by the NIHR Cambridge Biomedical Research Centre has found it may be possible to predict which patients will go on to develop severe or long-term COVID Read more

DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.Read more

Software tool will help doctors identify and prevent hospital transmission of SARS-CoV-2

A new software tool developed in Cambridge will help doctors identify where cases of COVID-19 were caused by transmission within a hospital, helping them to prevent further spread of the disease.Read more

alt=""
Age and pre-existing conditions increase risk of stroke among COVID-19 patients

Fourteen out of every 1,000 COVID-19 patients admitted to hospital experience a stroke, a rate that is even higher in older patients and those with severe infection and pre-existing vascular conditions, according to a report.Read more

alt=""
‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection

To better understand how SARS-CoV-2 infects the lungs and causes disease, a team of scientists from the UK and South Korea turned to organoids – ‘mini-organs’ grown in three dimensions to mimic the behaviour of tissue and organs.Read more

alt=""
Supporting research at Cambridge University Hospitals

As the COVID-19 situation develops, research staff at CUH continue our support of COVID-19 research studies, including Urgent Public Health Studies (UPH), while maintaining safe recruitment to existing open studies. Read more

Discover more

If you would like more information about NIHR Cambridge BRC, please contact us.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.